Background Heterologous vaccine regimens have been widely discussed as a way to
mitigate intermittent supply shortages and to improve immunogenicity and safety of COVID-19 …

COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection
to severe organ damage and death. We characterized the time-dependent progression of …

Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic,
there has been increasing urgency to identify pathophysiological characteristics leading to …

Severe COVID-19 is linked to both dysfunctional immune response and unrestrained
immunopathology, and it remains unclear whether T cells contribute to disease pathology. Here, …

We detected delayed and reduced antibody and T-cell responses after BNT162b2 vaccination
in 71 elderly persons (median age 81 years) compared with 123 healthcare workers (…

Global healthcare systems are challenged by the COVID-19 pandemic. There is a need to
optimize allocation of treatment and resources in intensive care, as clinically established risk …

One week after second vaccinations were administered, an outbreak of B. 1.1. 7 lineage
severe acute respiratory syndrome coronavirus 2 infections occurred in a long-term care facility …

Autophagy is a genetically regulated process of adaptation to metabolic stress and was
recently shown to be involved in the treatment response of chronic myeloid leukemia (CML). …

BACKGROUND After its introduction as standard-of-care for severe COVID-19, dexamethasone
has been administered to a large number of patients globally. Detailed knowledge of its …

Objectives Dexamethasone has become the standard of care for severe coronavirus disease
2019 (COVID-19), but its virological impact is poorly understood. The objectives of this …